The Human Trisome Project for Down Syndrome Research

This is an observational study called The Human Trisome Project. It aims to create a collection of biological samples and health information from people with and without Down syndrome. This collection, called a biobank, will help researchers better understand Down syndrome and related health conditions like Alzheimer's disease and heart defects. The study is looking to enroll 2500 participants between 6 months and 89 years old. Success for this study means enrolling enough participants to build a valuable biobank over five years. The current recruitment status is unclear.

Study design
This is an observational study with a planned enrollment of 2500 participants. It is not testing a specific drug or intervention.
What's involved
You would provide a blood sample, a mouth swab, and allow researchers to review your health information yearly for five years. Optional procedures include providing urine and/or stool samples and participating for a longer time.
Compensation
Not stated in the trial record.
Follow-up
Your health information will be reviewed yearly for five years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT02864108

The Human Trisome Project

Recruiting
Not specifiedAges 6–89Observational
University of Colorado, Denver
~2,500 participants
Updated 2025-10-24 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Participants and Controls Enrolled in Biobank
Measured over 5 years
Down Syndrome
Trisomy 21
1 sites across 1 states
Colorado1
  • Joaquin Espinosa, PhD · PRINCIPAL_INVESTIGATOR · Linda Crnic Institute for Down Syndrome at the University of Colorado Denver

Opens a ready-to-send draft in your own email app — review before sending.

  • Number of Participants and Controls Enrolled in Biobank5 years

    Create biobank of blood cells and plasma, saliva, mouth swab, urine, stool, and induced pluripotent stem cells (iPSC) cells for use in approved research projects.